Detailed Information
Cited 1 time in 
Cited 2 time in 
Cited 2 time in
Metadata Downloads
Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infantsopen access
- Authors
- Cho, Hye-Kyung; Park, Su Eun; Kim, Yae-Jean; Jo, Dae Sun; Kim, Yun-Kyung; Eun, Byung-Wook; Lee, Taek-Jin; Lee, Jina; Lee, Hyunju; Kim, Ki Hwan; Cho, Eun Young; Ahn, Jong Gyun; Choi, Eun Hwa
- Issue Date
- Dec-2021
- Publisher
- 대한소아청소년과학회
- Keywords
- Combined; Diphtheria-tetanus-acellular pertussis-inactivate; Infant; Vaccines
- Citation
- Clinical and Experimental Pediatrics, v.64, no.12, pp 602 - 607
- Pages
- 6
- Indexed
- SCOPUS
KCI
- Journal Title
- Clinical and Experimental Pediatrics
- Volume
- 64
- Number
- 12
- Start Page
- 602
- End Page
- 607
- ISSN
- 2713-4148
- Abstract
- In April 2020, the Ministry of Food and Drug Safety licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP), inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugated to tetanus protein, and hepatitis B (HepB) (recombinant DNA) vaccine, DTaP-IPV-Hib-HepB (Hexaxim, Sanofi Pasteur), for use as a 3-dose primary series in infants aged 2, 4, and 6 months. The DTaP-IPV-Hib-HepB vaccine is highly immunogenic and safe and provides a long-term immune response based on studies performed in a variety of settings in many countries, including Korea. This report summarizes the Committee on Infectious Diseases of the Korean Pediatric Society guidelines for the use of this newly introduced hexavalent combination vaccine. © 2021 by The Korean Pediatric Society.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 5. Others > ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Kim, Yun Kyung
- Ansan Hospital (Department of Pediatrics, Ansan Hospital)